PHIRE

Nearwave

Nearwave develops handheld, non-invasive near-infrared imaging devices to help oncologists and clinical researchers monitor breast cancer treatment efficacy and assess deep tissue biomarkers.

TRANSURETHRAL IMAGING & THERAPY

This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.

Refined Diagnostics

This company develops AI-powered laser imaging systems for real-time, stain-free tissue analysis and cancer diagnostics for surgeons, pathologists, and hospitals.

Neurolase

This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.

Deep Light Vision

This company develops quantum-enabled ultrasound optical tomography imaging devices for clinicians to diagnose breast cancer and monitor neonatal health.

MuReva Phototherapy

The company develops an intraoral light therapy device to prevent and treat oral mucositis in cancer patients undergoing radiation and chemotherapy.

BioPatch

BioPatch develops a non-invasive adhesive patch for breast cancer detection using electrical conductivity measurements for healthcare providers and patients.

Veriskin

Veriskin develops a handheld medical device using artificial intelligence to help primary care providers non-invasively detect skin cancer during routine physical examinations.